[go: up one dir, main page]

PL3638223T3 - Bromheksyna w leczeniu bólu - Google Patents

Bromheksyna w leczeniu bólu

Info

Publication number
PL3638223T3
PL3638223T3 PL18729456.6T PL18729456T PL3638223T3 PL 3638223 T3 PL3638223 T3 PL 3638223T3 PL 18729456 T PL18729456 T PL 18729456T PL 3638223 T3 PL3638223 T3 PL 3638223T3
Authority
PL
Poland
Prior art keywords
bromhexine
pain
treatment
Prior art date
Application number
PL18729456.6T
Other languages
English (en)
Inventor
Kai-Uwe Kern
Original Assignee
Kai-Uwe Kern
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kai-Uwe Kern filed Critical Kai-Uwe Kern
Publication of PL3638223T3 publication Critical patent/PL3638223T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL18729456.6T 2017-06-16 2018-06-13 Bromheksyna w leczeniu bólu PL3638223T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17176379.0A EP3415143A1 (en) 2017-06-16 2017-06-16 Bromhexine for the treatment of pain
PCT/EP2018/065646 WO2018229119A1 (en) 2017-06-16 2018-06-13 Bromhexine for the treatment of pain

Publications (1)

Publication Number Publication Date
PL3638223T3 true PL3638223T3 (pl) 2024-04-08

Family

ID=59070540

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18729456.6T PL3638223T3 (pl) 2017-06-16 2018-06-13 Bromheksyna w leczeniu bólu

Country Status (11)

Country Link
US (2) US11759439B2 (pl)
EP (2) EP3415143A1 (pl)
JP (2) JP7222930B2 (pl)
CN (1) CN110831585A (pl)
CA (1) CA3066904A1 (pl)
ES (1) ES2963708T3 (pl)
HR (1) HRP20240105T1 (pl)
HU (1) HUE065063T2 (pl)
PL (1) PL3638223T3 (pl)
RS (1) RS65014B1 (pl)
WO (1) WO2018229119A1 (pl)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1094864B (it) * 1978-05-29 1985-08-10 Tosi Franco Ist Derivati della bromexina e procedimento per la loro preparazione
US5256698A (en) * 1987-02-17 1993-10-26 University Of Iowa Research Foundation Treatment of psychosis using cyclohexyl-phenyl-lower alkyl amine derivatives
JPH1112167A (ja) * 1997-06-26 1999-01-19 Nitto Denko Corp 経皮吸収製剤
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
DE10208313A1 (de) 2002-02-27 2003-09-11 Boehringer Ingelheim Pharma Ambroxol für die Behandlung von schmerzhaften Zuständen im Mund und Rachenraum
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
JP2007530620A (ja) * 2004-04-01 2007-11-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物
US20060019969A1 (en) * 2004-07-24 2006-01-26 Laboratorios Dr. Esteve S.A. Use of compounds active on the sigma receptor for the treatment of allodynia
ES2651021T3 (es) 2004-07-24 2018-01-23 Laboratorios Del Dr. Esteve, S.A. Uso de compuestos activos sobre el receptor sigma para el tratamiento de alodinia mecánica
JP2006124381A (ja) * 2004-09-29 2006-05-18 Dai Ichi Seiyaku Co Ltd 炎症の予防および/または治療薬
WO2007098939A1 (en) * 2006-02-28 2007-09-07 Laboratorios Del Dr. Esteve, S.A. Use of compounds binding to the sigma receptor for the treatment of metabolic syndrome
KR20110008166A (ko) * 2008-02-18 2011-01-26 라보라토리오스 델 드라. 에스테브.에스.에이. 화학요법의 결과로 발생하는 신경병적 통증의 치료를 위한 시그마 수용체 리간드에 결합하는 화합물들의 용도
JP2010215611A (ja) * 2009-01-28 2010-09-30 Kowa Co ロキソプロフェン含有医薬製剤
WO2011093498A1 (ja) * 2010-01-29 2011-08-04 興和株式会社 ロキソプロフェン含有医薬組成物
EP2460519A1 (en) * 2010-12-03 2012-06-06 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in bone cancer pain
CN102702001B (zh) * 2012-07-06 2013-08-07 天津梅花医药有限公司 稳定的无定型盐酸氨溴索化合物
MX2016002892A (es) * 2013-09-12 2016-06-10 Esteve Labor Dr Combinaciones de ligando de receptores sigma y aine.

Also Published As

Publication number Publication date
EP3638223B1 (en) 2023-10-25
CN110831585A (zh) 2020-02-21
EP3638223A1 (en) 2020-04-22
EP3638223C0 (en) 2023-10-25
JP2020523395A (ja) 2020-08-06
US11759439B2 (en) 2023-09-19
CA3066904A1 (en) 2018-12-20
HRP20240105T1 (hr) 2024-05-10
EP3415143A1 (en) 2018-12-19
HUE065063T2 (hu) 2024-05-28
JP7222930B2 (ja) 2023-02-15
US20200197330A1 (en) 2020-06-25
ES2963708T3 (es) 2024-04-01
WO2018229119A1 (en) 2018-12-20
RS65014B1 (sr) 2024-01-31
US20230390216A1 (en) 2023-12-07
JP2023016808A (ja) 2023-02-02

Similar Documents

Publication Publication Date Title
ZA202006746B (en) Methods of treatment
IL275482A (en) Asketamine for the treatment of depression
GB201804514D0 (en) Treatment of pyroptosis
IL262825A (en) Tetrahydropyridine and tetrahydropyrimidine substances, preparations containing them and their use for pain treatment
IL276482A (en) Compounds for pain management
ZA201705847B (en) Treatment of pain
GB201804515D0 (en) Treatment of necroptosis
PL3448340T3 (pl) Pomocniczy element aplikacyjny do opatrywania ran
GB201604658D0 (en) Treatment for pain
SG11202005850VA (en) Methods of treatment of hypertrigl yceridemia
IL266243A (en) Use of senicapoc for the treatment of neuropathic pain
IL258316A (en) A combination of trazodone and gabapentin for the treatment of pain
ZA202002910B (en) Treatment of skin disorders
IL273364A (en) MPGES-1 inhibitor for the treatment of osteoarthritis pain
PL3638223T3 (pl) Bromheksyna w leczeniu bólu
GB201801249D0 (en) Methods of treatment
HK40006632A (en) Treatment of pain
GB201701936D0 (en) New methods for the treatment of hyperglycaemia
GB201701933D0 (en) New methods for the treatment of hyperglycaemia
AU2016901912A0 (en) Treatment of Pain
GB201703768D0 (en) Skin treatment methods
GB201703734D0 (en) Skin treatment methods
GB201505205D0 (en) Treatment for pain
GB201504688D0 (en) Treatment for pain